# The Treatment Advocacy Program

> **NCT00164333** · PHASE2 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 300 (—)

## Conditions studied

- HIV

## Interventions

- **BEHAVIORAL:** TAP: Treatment Advocacy Program

## Key facts

- **NCT ID:** NCT00164333
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-05
- **Final completion:** 2008-04
- **Target enrollment:** 300 (—)
- **Last updated:** 2012-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164333, "The Treatment Advocacy Program". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00164333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*